Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Devon Herrick

Americans are Struggling with Medical Bills, but Congress Cannot Agree on Solutions

Posted on November 27, 2025November 27, 2025 by Devon Herrick

Americans are struggling with medical bills. This news is from charities that assist patients with medical bills. Critics point to President Trump’s One Big Beautiful Bill as exacerbating the problem. They argue cutting Medicaid eligibility and not extending the enhanced subsidies for Obamacare as raising costs for some Americans. Even with insurance medical bills strain budgets.

+

NPR: Fewer Physicians Trained Abroad Want to Practice Medicine in U.S.

Posted on November 24, 2025 by Devon Herrick

More than one-quarter of applicants for U.S. residency programs are foreign medical graduates. In 2025, 9,761 international medical graduates matched to a residency program in the U.S. out of a pool estimated to be as high as 15,000 who wanted to come. Some of these were U.S. citizens attending school abroad, but most were foreign born and educated abroad.

+

NYT: People Turn to AI Chatbots When Doctors Are Too Busy

Posted on November 21, 2025November 19, 2025 by Devon Herrick

Consumers are beginning to use AI for more than just entertainment and trivia. Many patients are using AI chatbots for mental health counseling and to answer medical questions they are unable to get from their doctors.

+

When Drug Patents Become an Impenetrable Thicket that Stifles Innovation

Posted on November 19, 2025 by Devon Herrick

While patents are designed to reward innovation, patents can also stifle innovation. Take drugmakers for example. It is expensive for drugmakers to innovate. Each new product as to go through Phase 0, 1, 2 and 3 testing. With each new product, drug companies must apply for a new drug application, called an NDA.

+
  • Previous
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 197
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom